A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis.
N Engl J Med. 2006 Mar 2;354(9):899-910. doi: 10.1056/NEJMoa044397.
N Engl J Med. 2006.
PMID: 16510744
Free article.
Clinical Trial.